Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006;36(3):252-6.
doi: 10.1007/s00595-005-3143-z.

Onset of liver metastasis after histologically curative resection of pancreatic cancer

Affiliations

Onset of liver metastasis after histologically curative resection of pancreatic cancer

Katsuhiko Inoue et al. Surg Today. 2006.

Abstract

Purpose: We assessed the possibility of predicting the time of onset of liver metastases by measuring the postoperative changes in serum carbohydrate antigen (CA)19-9 after curative resection of pancreatic cancers.

Methods: Among 28 patients who underwent histologically defined curative resection of pancreatic cancer between 1984 and 1999, liver metastasis developed in 11 patients with elevated serum CA19-9 levels. We plotted the serum CA19-9 levels against time on a semilogarithmic graph. Over the linear part of the curve, the time when log[CA19-9] equaled zero was defined as the time of onset of liver metastases. The log[CA19-9] level doubling time was then calculated and evaluated in relation to the survival period.

Results: The serum CA19-9 levels increased linearly in 10 of the 11 patients. The predicted time of onset of liver metastasis ranged from preoperative day 163.0 to postoperative day 27.1, being preoperative in eight patients. The doubling time until death correlated strongly with survival in the eight patients with maintained log[CA19-9] linearity.

Conclusion: The onset of liver metastases might be preoperative in patients with advanced pancreatic cancer. Therefore, neoadjuvant chemotherapy should be mandatory even if there is no sign of liver metastases.

PubMed Disclaimer

References

    1. Hepatogastroenterology. 1998 Jan-Feb;45(19):253-9 - PubMed
    1. J Gastrointest Surg. 1998 Jan-Feb;2(1):28-35 - PubMed
    1. Int J Pancreatol. 1995 Apr;17(2):139-46 - PubMed
    1. Int J Biol Markers. 1999 Apr-Jun;14(2):99-105 - PubMed
    1. Ann Surg Oncol. 1997 Oct-Nov;4(7):551-6 - PubMed

LinkOut - more resources